| 期刊論文1. | Yeh, C.-J.、Chang, H.-Y.、Pan, W.-H.(2011)。Time trend of obesity, the metabolic syndrome and related dietary pattern in Taiwan: From NAHSIT 1993-1996 to NAHSIT 2005-2008。Asia Pacific Journal of Clinical Nutrition,20(2),292-300。 | 2. | Kurzthaler, I. K.、Fleischhaker, W. W.(2001)。The clinical implications of weight gain in schizophrenia。Journal of Clinical Psychiatric,62(Suppl. 7),32-37。 | 3. | Must, A.、Dietz, W. H.、Spandano, J.、Coakley, E. H.、Field, A. E.、Colditz, G.(1999)。The disease burden associated with overweight and obesity。Journal of the American Medical Association,282,1523-1529。 | 4. | Brown, S.、Inskip, H.、Barraclough, B.(2000)。Causes of the excess mortality of schizophrenia。British Journal of Psychiatry,177,212-217。 | 5. | Huang, M. C.、Lu, M. L.、Tsai, C. J.、Chen, P. Y.、Chiu, C. C.、Jian, D. L.、Chen, C. H.(2009)。Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan。Acta Psychiatrica Scandinavica,120,274-280。 | 6. | Allison, D. B.、Newcomer, J. W.、Dunn, A. L.、Blumenthal, J. A.、Fabricatore, A. N.、Daumit, G. L.、Cope, M. B.、Riley, W. T.、Vreeland, B.、Hibbeln, J. R.、Alpert, J. E.(2009)。Obesity among those with mental disorders: a National Institute of Mental Health meeting report。American journal of preventive medicine,36(4),341-350。 | 7. | Colton, CW、Manderscheid, RW(2006)。Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states。Prev Chronic Dis,3,A42。 | 8. | Osby, U、Correia, N、Brandt, L、Ekbom, A、Sparen, P(2000)。Mortality and causes of death in schizophrenia in Stockholm county, Sweden。Schizophr Res,29,21-28。 | 9. | Auquier, P.、Lancon, C.、Rouillon, F.、Lader, M.(2007)。Mortality in schizophrenia。Pharmacoepidemiology and Drug Safety,16(12),1308-1312。 | 10. | Oud, MJ、Jong, BM(2009)。Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care。BMC Fam Pract,10,32。 | 11. | De Hert, MA、Winkel, R、Van Eyck, D(2006)。Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication。Schizophr Res,83,87-93。 | 12. | Allison, DB、Casey, DE(2001)。Antipsychotic-induced weight gain: a review of the literature。J Clin Psychiatry,62,22-31。 | 13. | Reist, C、Mintz, J、Albers, LJ、Jamal, MM、Szabo, S、Ozdemir, V(2007)。Second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia: an observational pharmacoepidemiology study from 1988 to 2002。Clin Psychopharmacol,27,46-51。 | 14. | Bell, RC、Farmer, S、Ries, R、Srebnik, D(2009)。Metabolic risk factors among medicaid outpatients with schizophrenia receiving second-generation antipsychotics。Psychiatr Serv,60,1686-1689。 | 15. | Bobes, J、Arango, C、Aranda, P、Carmena, R、Garcia-Garcia, M、Rejas, J(2007)。Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study。Schizophr Res,90,162-173。 | 16. | Coodin, S(2001)。Body mass index in persons with schizophrenia。Can J Psychiatry,46,549-555。 | 17. | Hsiao, CC、Ree, SC、Chiang, YL、Yeh, SS、Chen, CK(2004)。Obesity in schizophrenic outpatients receiving antipsychotics in Taiwan。Psychiatry Clin Neurosci,58,403-409。 | 18. | Poulin, MJ、Chaput, JP、Simard, V(2007)。Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme。Aust N Z Psychiatry,41,980-989。 | 19. | Sugawara, N、Yasui-Furukori, N、Sato, Y(2011)。Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia。Ann Gen Psychiatry,10,21。 | 20. | Hakko, H、Komulainen, M、Koponen, H(2006)。Are females at special risk of obesity if they become psychotic? the longitudinal Northern Finland 1966 Birth Cohort Study。Schizophr Res,84,15-9。 | 21. | McEvoy, J. P.、Meyer, J. M.、Goff, D. C.(2005)。Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III。Schizophr Res,80,19-32。 | 22. | Kuruvilla, A、Peedicayil, J、Srikrishna, G、Kuruvilla, K、Kanagasabapathy, AS(1992)。A study of serum prolactin in schizophrenia: comparison of males and females。Clin Exp Pharmacol Physiol,19,603-606。 | 23. | Smith, S、Wheeler, MJ、Murray, R、O’Keane, V(2002)。The effect of antipsychotic-induced hyperprolactinemia on the hypothalamic-pituitary-gonadal axis。J Clin Psychopharmacol,22,109-114。 | 24. | Wieck, A、Haddad, PM(2003)。Antipsychotic-induced hyper-prolactinaemia in women: pathophysiology, severity and consequences。Br J Psychiatry,182,199-204。 | 25. | Choi, SB、Jang, JS、Park, S(2005)。Estrogen and exercise may enhance beta-cell function and mass via IRS2 induction in ovariectomized diabetic rats。Endocrinology,146,4786-4794。 | 26. | Gerozissis, K(2008)。Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies。Eur J Pharmacol,585,38-49。 | 27. | Park, S、Sang, MH、I1, SA、Sung, HK(2010)。Olanzapine, not resperidone, exacerbates beta-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them。J Psychopharmacol,24,1105-1114。 | 28. | Duvnjak, L、Duvnjak, M(2009)。The metabolic syndrome - an ongoing story。J Physiol Pharmacol,60,19-24。 | 29. | Taylor, T. L.、Killaspy, H.、Wright, C.(2009)。A systematic review of the international published literature relating to quality of institutional care for people with longer term mental health problems。BMC Psychiatry,9,55。 | 30. | Bigaard, J、Frederikse, K、Tjonneland, A(2005)。Waist circumference and body composition in relation to all-cause mortality in middle-aged men and women。Int J Obes,29,778-784。 | 31. | Wei, M.、Gaskill, S. P.、Haffner, S. M.、Stern, M. P.(1997)。Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans: a 7-year prospective study。Obesity research,5(1),16-23。 | |
| |